1. Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitors for cancer therapy. (October 2020) Authors: Miles, D.; Chen, Y.; Paprcka, S.L.; Foley, C.N.; Grange, R.; Leleti, M.R.; Zhao, X.; Jin, L.; Young, S.W.; Walters, M.J.; Powers, J.P. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗